Highlights and Quick Summary
- Average Payables for the quarter ending June 30, 2023 was $2 Million (a -14.04% decrease compared to previous quarter)
- Year-over-year quarterly Average Payables decreased by -17.47%
- Annual Average Payables for 2022 was $2.32 Million (a 53.86% increase from previous year)
- Annual Average Payables for 2021 was $1.51 Million (a 0.0% decrease from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Payables of Design Therapeutics, Inc.
Most recent Average Payablesof DSGN including historical data for past 10 years.Interactive Chart of Average Payables of Design Therapeutics, Inc.
Design Therapeutics, Inc. Average Payables for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $2.0 | $2.32 | – | – | – |
| 2022 | $2.32 | $2.42 | $1.83 | $1.97 | $2.32 |
| 2021 | – | – | $1.51 | $0.01 | $1.51 |
| 2020 | $1.51 | $0.01 | – | – | $1.51 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology